Surge in prevalence of eye diseases and increase in government initiatives to control visual impairment propel the growth of the market

PORTLAND, OREGON, US, December 3, 2021 /EINPresswire.com/ -- Allied Market Research published a report, titled, "Artificial Cornea and Corneal Implant Market: Global Opportunity Analysis and Industry Forecast, 2021–2028." According to the report, the global artificial cornea and corneal implant market was pegged at $376.61 million in 2020, and is anticipated to reach $656.19 million by 2028, manifesting a CAGR of 7.9% from 2021 to 2028.

Access Full Summary: https://www.alliedmarketresearch.com/request-sample/11698

Surge in prevalence of eye diseases and increase in government initiatives to control visual impairment propel the growth of the global artificial cornea and corneal implant market. Conversely, high cost of ophthalmology devices and surgical procedures along with low accessibility to eye care in low-income countries impede the market growth. However, demand for minimally invasive surgical procedures offers lucrative opportunities in the coming years.

Covid-19 Scenario:
• Owing to the outbreaks of the pandemic, the government bodies put certain restrictions and bans on specific medical procedures and surgeries to avoid the spread of the coronavirus. Among those procedures, artificial cornea and corneal implant procedures were conducted only in case of emergencies.
• At the same time, artificial cornea manufacturers witnessed issues such as carrying out in-person product demonstrations, operating facilities at full capacity, and organizing or attending conferences.
• The lockdown imposed in Asia-Pacific countries such as China and India hindered the manufacturing activities and shipment of ophthalmic devices due to ban on import-export activities.

Based on type, the human cornea segment accounted for the highest market share in 2019, with nearly four-fifths of the total share in 2019, and is expected to uphold its dominant position in terms of revenue by 2028. This is attributed to the rising awareness regarding corneal transplantation and eye tissue donations, especially in developing economies. Conversely, the artificial cornea segment is estimated to exhibit the fastest CAGR of 8.5% from 2021 to 2028. This is owing to the prevalence of eye disease, chronic infections across the globe.

For Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/11698

Based on transplant type, the penetrating keratoplasty segment dominated with largest share, holding for nearly two-fifths of the global artificial cornea and corneal implant market in 2019, and is likely to maintain its lead position during the forecast period. This is owing to the rising number of people suffering from eye disorders such as infectious keratitis and injury of the eyeball. However, the keratoprosthesis segment is estimated to represent the highest CAGR of 9.8% from 2021 to 2028. This is due to the prevalance of eye disease, increase in rejection of human cornea.

Based on region, the market across North America held the highest market share in 2019, with more than two-fifths of the total market, and is projected to maintain its leadership status by 2028. This is attributed to the established healthcare infrastructure, higher adoption of sophisticated healthcare technologies, higher budget among end users of ophthalmic devices, and a large number of manufacturers for corneal implants in the region. Nevertheless, Asia-Pacific is anticipated to portray the largest CAGR of 8.7% during the forecast period.

Leading market players-

• AJL Ophthalmic
• CorNeat Vision
• CorneaGen Inc.
• Presbia plc
• LinkoCare Life Sciences AB
• Aurolab
• Mediphacos
• DIOPTEX GmbH
• Cornea Biosciences
• EyeYon Medical.

Similar Reports:

Eye Drops and Lubricants Market
Eye Care Surgical Market
Eye Testing Equipment Market

About Us:

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn